Report overview
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines. This report contains market size and forecasts of Hepatitis B Vaccines in global, including the following market information:
Global Hepatitis B Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis B Vaccines Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Hepatitis B Vaccines companies in 2022 (%)
The global Hepatitis B Vaccines market was valued at US$ 1051.4 million in 2022 and is projected to reach US$ 1184.9 million by 2029, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
We surveyed the Hepatitis B Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, by Type, 2022 (%)
Yeast Derived
CHO Derived
Global Hepatitis B Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, by Application, 2022 (%)
Children
Adult
Global Hepatitis B Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis B Vaccines revenues share in global market, 2022 (%)
Key companies Hepatitis B Vaccines sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Hepatitis B Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B Vaccines, market overview.
Chapter 2: Global Hepatitis B Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis B Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
